Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-08 4:17 pm Purchase | 2024-06-28 | 13G | Recursion Pharmaceuticals, Inc. RXRX | RA Capital Management, L.P. | 15,384,615 5.900% | 15,384,615![]() (New Position) | Filing History |
| 2024-07-01 9:31 pm Purchase | 2024-06-21 | 13G | Praxis Precision Medicines, Inc. PRAX | RA Capital Management, L.P. | 1,235,599 7.200% | 1,235,599![]() (New Position) | Filing History |
| 2024-07-01 9:28 pm Purchase | 2024-06-27 | 13D | Climb Bio, Inc. CLYM | RA Capital Management, L.P. | 31,459,267 47.100% | 18,268,418![]() (+138.49%) | Filing History |
| 2024-06-24 5:06 pm Purchase | 2024-06-13 | 13G | Perceptive Capital Solutions Corp Class A Ordinary Shares PCSC | RA Capital Management, L.P. | 750,000 8.400% | 750,000![]() (New Position) | Filing History |
| 2024-06-20 6:00 pm Purchase | 2024-06-17 | 13D | Aerovate Therapeutics, Inc. AVTE | RA Capital Management, L.P. | 264,060 32.000% | 26,517![]() (+11.16%) | Filing History |
| 2024-06-17 8:50 pm Purchase | 2024-06-06 | 13G | Evolent Health, Inc. EVH | RA Capital Management, L.P. | 8,279,103 7.100% | 8,279,103![]() (New Position) | Filing History |
| 2024-06-12 6:26 pm Purchase | 2024-06-11 | 13D | Solid Biosciences Inc. SLDB | RA Capital Management, L.P. | 4,358,478 11.300% | 9,650![]() (+0.22%) | Filing History |
| 2024-06-07 4:18 pm Purchase | 2024-05-28 | 13G | Bicycle Therapeutics plc BCYC | RA Capital Management, L.P. | 2,253,000 5.000% | 2,253,000![]() (New Position) | Filing History |
| 2024-06-06 4:16 pm Purchase | 2024-06-04 | 13D | Climb Bio, Inc. CLYM | RA Capital Management, L.P. | 13,190,849 44.300% | 557![]() (+0.00%) | Filing History |
| 2024-06-03 8:53 pm Purchase | 2024-05-23 | 13G | Tourmaline Bio, Inc. TRML | RA Capital Management, L.P. | 2,045,028 8.000% | 2,045,028![]() (New Position) | Filing History |
| 2024-05-30 6:57 pm Purchase | 2024-05-20 | 13G | Structure Therapeutics Inc. GPCR | RA Capital Management, L.P. | 7,225,311 5.200% | 7,225,311![]() (New Position) | Filing History |
| 2024-05-17 4:18 pm Purchase | 2024-05-15 | 13D | Climb Bio, Inc. CLYM | RA Capital Management, L.P. | 13,190,292 45.300% | 556![]() (+0.00%) | Filing History |
| 2024-05-14 9:10 pm Sale | 2024-05-10 | 13D | iTeos Therapeutics, Inc. ITOS | RA Capital Management, L.P. | 3,659,046 9.990% | -758,213![]() (-17.16%) | Filing History |
| 2024-05-10 5:52 pm Purchase | 2024-04-30 | 13G | MEDICENNA THERAPEUTICS CORP MDNAF | RA Capital Management, L.P. | 7,714,760 9.990% | 7,714,760![]() (New Position) | Filing History |
| 2024-05-09 8:48 pm Purchase | 2024-05-07 | 13D | Black Diamond Therapeutics, Inc. BDTX | RA Capital Management, L.P. | 2,788,028 4.950% | 198,124![]() (+7.65%) | Filing History |
| 2024-05-07 4:52 pm Purchase | 2024-05-03 | 13D | Werewolf Therapeutics, Inc. HOWL | RA Capital Management, L.P. | 6,192,881 14.200% | 13,846![]() (+0.22%) | Filing History |
| 2024-05-06 5:57 pm Purchase | 2024-04-26 | 13G | Avidity Biosciences, Inc. RNA | RA Capital Management, L.P. | 4,895,959 5.100% | 2,441,426![]() (+99.47%) | Filing History |
| 2024-05-02 5:58 pm Purchase | 2024-04-22 | 13G | Zura Bio Limited ZURA | RA Capital Management, L.P. | 3,217,503 5.100% | 3,217,503![]() (New Position) | Filing History |
| 2024-04-30 4:16 pm Purchase | 2024-04-26 | 13D | Aerovate Therapeutics, Inc. AVTE | RA Capital Management, L.P. | 237,542 28.900% | 595![]() (+0.25%) | Filing History |
| 2024-04-25 8:43 pm Purchase | 2024-04-10 | 13G | Protara Therapeutics, Inc. TARA | RA Capital Management, L.P. | 2,073,075 9.990% | 2,073,075![]() (New Position) | Filing History |

